QID 242105

Date Published: 2023-10-09

QID 242105: Red Hat Update for JBoss Enterprise Application Platform 7.4.1 on RHEL 9 (RHSA-2023:5486)

Red hat jboss enterprise application platform 7 is a platform for java applications based on the wildfly application runtime...Security Fix(es):

    server: eap-7: heap exhaustion via deserialization (cve-2023-3171).
    Log4j: log4j1-chainsaw, log4j1-socketappender: dos via hashmap logging (cve-2023-26464).
    Nodejs-semver: regular expression denial of service (cve-2022-25883).
    Wildfly-core: management user rbac permission allows unexpected reading of system-properties to an unauthorized actor (cve-2023-4061).
    Tough-cookie: prototype pollution in cookie memstore (cve-2023-26136).
    Bouncycastle: potential blind ldap injection attack using a self-signed certificate (cve-2023-33201).
    Netty: netty-handler: snihandler 16mb allocation (cve-2023-34462).
Affected Products:
    jboss enterprise application platform 7.4 for rhel 9 x86_64.
.

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Critical - 9.8 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Refer to Red Hat security advisory RHSA-2023:5486 for updates and patch information.
    Vendor References

    CVEs related to QID 242105

    CVE-2022-25883 | CVE-2023-3171 | CVE-2023-4061 | CVE-2023-26136 | CVE-2023-26464 | CVE-2023-33201 | CVE-2023-34462 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2023:5486 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2023:5486
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].